Research from Tech in Asia, Tech in Asia

Tech in Asia

Research from Tech in Asia

Tech in Asia (YC W15) is the largest English-language technology media company that focuses on Asia. From the latest news to the hottest trends and the boldest startups to the strongest titans, we cover everything tech in the region. Our goal is to build and serve Asia’s tech and startup community.

News from Tech in Asia

Private Capital Markets

<ul><li><a href="https://www.halodoc.com/" target="_blank" rel="noopener">Halodoc</a>, the Indonesia-based healthtech firm, raked in US$100 million in series D funding in a round led by returning investor <a href="https://www.astra.co.id/" target="_blank" rel="noopener">Astra Digital International</a>, according to a statement.</li><li>This boosts Astra’s total investments in the company to US$135 million. In 2021, the local conglomerate also led the <a href="https://www.techinasia.com/singapores-temasek-joins-80m-indonesian-healthtech-firm-halodoc" target="_blank" rel="noopener">US$80 million</a> series C round of Halodoc.</li><li>With the new capital, Halodoc has raised at least US$258 million, according to Tech in Asia data.</li></ul>

Halodoc, the Indonesia-based healthtech firm, raked in US$100 million in series D funding in a round led by returning investor Astra Digital International, according to a statement.This boosts Astra’s total investments in the company to US$135 million. In 2021, the local conglomerate also led the US$80 million series C round of Halodoc.With the new capital, Halodoc has raised at least US$258 million, according to Tech in Asia data.

Halodoc Raises $100m Series D in Astra-Led Round

Thematic (Sector/Industry)

<ul><li>Badan Pengawas Obat dan Makanan (BPOM), Indonesia’s national food and drug agency, told Tech in Asia that it holds the electronic pharmaceutical system operators – or PSEF – responsible for the sale of prohibited drugs on their platforms.</li><li><p>Licensed online pharmacies are accountable because they have “full control over the content and products that are displayed,” the regulator said.</p></li><li>This implies that as a marketplace, Halodoc is not responsible for the sale of any restricted drugs, but BPOM’s responses indicate otherwise.</li></ul>

Badan Pengawas Obat dan Makanan (BPOM), Indonesia’s national food and drug agency, told Tech in Asia that it holds the electronic pharmaceutical system operators – or PSEF – responsible for the sale of prohibited drugs on their platforms.Licensed online pharmacies are accountable because they have “full control over the content and products that are displayed,” the regulator said.This implies that as a marketplace, Halodoc is not responsible for the sale of any restricted drugs, but BPOM’s responses indicate otherwise.

Indonesian Regulator Holds E-Pharmacies Responsible for Selling Restricted Drugs

Indonesia

Media Dokter Investama PT, doing business as HaloDoc, operates as a digital health care application. The Company offers platform that provides information about health checkup, diseases, medicines and vitamins, hospitals, and doctors. HaloDoc serves patients in Indonesia.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Halodoc (1437709D IJ)

Halodoc Raises $100m Series D in Astra-Led Round

Halodoc, the Indonesia-based healthtech firm, raked in US$100 million in series D funding in a round led by returning investor Astra Digital...

Tech in Asia

Indonesian Regulator Holds E-Pharmacies Responsible for Selling Restricted Drugs

Badan Pengawas Obat dan Makanan (BPOM), Indonesia’s national food and drug agency, told Tech in Asia that it holds the electronic pharmaceutical...

Tech in Asia

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)